De-Lei Cheng

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Prognostic Factors

Patient Reported Outcomes

Ejection Fraction

Radiofrequency Ablation

Top Venues

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Liang Yin, Kai-Cai Liu, Wei-Fu Lv, Shao-Bao Xu, Dong Lu, Chun-Ze Zhou, De-Lei Cheng, Zong-Gen Gao, Chang-Sheng Shi, Ming-Xue Su
Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation. Drug design, development and therapy 16 (2022)
Kai-Cai Liu, Ying-Hong Hao, Wei-Fu Lv, Wei-Dong Jia, Chu-Shu Ji, Chun-Ze Zhou, De-Lei Cheng, Shao-Bao Xu, Zong-Gen Gao, Ming-Xue Su, Chang-Sheng Shi
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma. Drug design, development and therapy 14 (2020)